HUP0204391A3 - The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders - Google Patents
The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disordersInfo
- Publication number
- HUP0204391A3 HUP0204391A3 HU0204391A HUP0204391A HUP0204391A3 HU P0204391 A3 HUP0204391 A3 HU P0204391A3 HU 0204391 A HU0204391 A HU 0204391A HU P0204391 A HUP0204391 A HU P0204391A HU P0204391 A3 HUP0204391 A3 HU P0204391A3
- Authority
- HU
- Hungary
- Prior art keywords
- mirtazapine
- preparation
- treatment
- pharmaceutical composition
- composition suitable
- Prior art date
Links
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title 1
- 229960001785 mirtazapine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000019116 sleep disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00200499 | 2000-02-11 | ||
| PCT/EP2001/001221 WO2001058453A1 (en) | 2000-02-11 | 2001-02-06 | The use of mirtazapine for the treatment of sleep disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0204391A2 HUP0204391A2 (en) | 2003-05-28 |
| HUP0204391A3 true HUP0204391A3 (en) | 2005-03-29 |
Family
ID=8171013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0204391A HUP0204391A3 (en) | 2000-02-11 | 2001-02-06 | The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6933293B2 (enExample) |
| EP (4) | EP1656937A1 (enExample) |
| JP (1) | JP5039994B2 (enExample) |
| KR (1) | KR20020069371A (enExample) |
| CN (2) | CN1395487A (enExample) |
| AR (1) | AR027394A1 (enExample) |
| AT (1) | ATE317261T1 (enExample) |
| AU (1) | AU780439B2 (enExample) |
| BR (1) | BR0108261A (enExample) |
| CA (1) | CA2396209C (enExample) |
| CO (1) | CO5271706A1 (enExample) |
| CZ (1) | CZ302368B6 (enExample) |
| DE (1) | DE60117122T2 (enExample) |
| DK (1) | DK1257278T3 (enExample) |
| ES (1) | ES2258071T3 (enExample) |
| HK (1) | HK1049122B (enExample) |
| HU (1) | HUP0204391A3 (enExample) |
| IL (2) | IL150290A0 (enExample) |
| NO (1) | NO328007B1 (enExample) |
| PE (1) | PE20011080A1 (enExample) |
| PL (1) | PL206073B1 (enExample) |
| RU (1) | RU2270680C2 (enExample) |
| SK (1) | SK287396B6 (enExample) |
| WO (1) | WO2001058453A1 (enExample) |
| ZA (1) | ZA200205238B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040152055A1 (en) * | 2003-01-30 | 2004-08-05 | Gliessner Michael J.G. | Video based language learning system |
| UA83666C2 (ru) | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
| EP1689371A2 (en) * | 2003-11-25 | 2006-08-16 | Aurobindo Pharma Limited | Pharmaceutical compositions of mirtazapine |
| GB0417558D0 (en) * | 2004-08-06 | 2004-09-08 | Merck Sharp & Dohme | Novel combination therapy |
| EP1806133A1 (en) * | 2004-10-14 | 2007-07-11 | Daikin Industries, Ltd. | Method for modifying the ambience, and spray liquid and sprayer used in the method |
| JP2006137748A (ja) * | 2004-10-14 | 2006-06-01 | Daikin Ind Ltd | 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置 |
| JP2007284363A (ja) * | 2006-04-13 | 2007-11-01 | Daikin Ind Ltd | 噴霧剤 |
| CN101679431B (zh) | 2007-04-11 | 2013-08-14 | Msd欧斯股份有限公司 | 制备四环苯并氮杂卓的对映异构体的方法 |
| JP6876003B2 (ja) | 2015-02-27 | 2021-05-26 | デクラ リミテッド | イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置 |
| CN111053735A (zh) * | 2020-02-25 | 2020-04-24 | 上海阶平医院管理有限公司 | 一种治疗失眠的冷敷凝胶 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189199C (nl) | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| DE69307908T2 (de) * | 1992-10-07 | 1997-07-10 | Akzo Nobel Nv | Verfahren zur trennung von enantiomeren aus einer racemischen mischung |
| IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
| EP0813873B1 (en) | 1996-06-19 | 2002-02-13 | Akzo Nobel N.V. | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
| WO1999025356A1 (en) | 1997-11-14 | 1999-05-27 | Akzo Nobel N.V. | Use of mirtazapine for treating sleep apneas |
-
2001
- 2001-02-06 EP EP05109547A patent/EP1656937A1/en not_active Ceased
- 2001-02-06 IL IL15029001A patent/IL150290A0/xx unknown
- 2001-02-06 DE DE60117122T patent/DE60117122T2/de not_active Expired - Lifetime
- 2001-02-06 CN CN01803934A patent/CN1395487A/zh active Pending
- 2001-02-06 CN CNA2008100056868A patent/CN101229170A/zh active Pending
- 2001-02-06 AU AU30247/01A patent/AU780439B2/en not_active Expired
- 2001-02-06 EP EP10178745A patent/EP2283840A1/en not_active Withdrawn
- 2001-02-06 SK SK1144-2002A patent/SK287396B6/sk not_active IP Right Cessation
- 2001-02-06 HK HK03101379.6A patent/HK1049122B/en not_active IP Right Cessation
- 2001-02-06 DK DK01902410T patent/DK1257278T3/da active
- 2001-02-06 WO PCT/EP2001/001221 patent/WO2001058453A1/en not_active Ceased
- 2001-02-06 BR BR0108261-2A patent/BR0108261A/pt not_active Application Discontinuation
- 2001-02-06 EP EP01902410A patent/EP1257278B1/en not_active Expired - Lifetime
- 2001-02-06 JP JP2001557563A patent/JP5039994B2/ja not_active Expired - Lifetime
- 2001-02-06 RU RU2002124141/15A patent/RU2270680C2/ru not_active IP Right Cessation
- 2001-02-06 AT AT01902410T patent/ATE317261T1/de active
- 2001-02-06 EP EP05109549A patent/EP1658850A1/en not_active Withdrawn
- 2001-02-06 US US10/203,232 patent/US6933293B2/en not_active Expired - Lifetime
- 2001-02-06 ES ES01902410T patent/ES2258071T3/es not_active Expired - Lifetime
- 2001-02-06 CZ CZ20022330A patent/CZ302368B6/cs not_active IP Right Cessation
- 2001-02-06 CA CA002396209A patent/CA2396209C/en not_active Expired - Lifetime
- 2001-02-06 HU HU0204391A patent/HUP0204391A3/hu unknown
- 2001-02-06 KR KR1020027009536A patent/KR20020069371A/ko not_active Ceased
- 2001-02-06 PL PL356721A patent/PL206073B1/pl not_active IP Right Cessation
- 2001-02-08 PE PE2001000141A patent/PE20011080A1/es not_active Application Discontinuation
- 2001-02-09 AR ARP010100585A patent/AR027394A1/es unknown
- 2001-02-09 CO CO01009904A patent/CO5271706A1/es not_active Application Discontinuation
-
2002
- 2002-06-18 IL IL150290A patent/IL150290A/en not_active IP Right Cessation
- 2002-06-28 ZA ZA200205238A patent/ZA200205238B/en unknown
- 2002-08-09 NO NO20023803A patent/NO328007B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
| HUP0301167A3 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders, process for their preparation, pharmaceutical compositions containing them and their use | |
| IL157734A0 (en) | Pharmaceutical compositions for the treatment of urogenital disorders | |
| GB0007193D0 (en) | Treatment of movrmrnt disorders | |
| IL219397A0 (en) | Compounds for the treatment of metabolic disorders, methods of preparing same, and pharmaceutical compositions containing same | |
| HUP0400529A3 (en) | Use of chlorpromazine and pentamidine for preparation of pharmaceutical compositions for the treatment of neoplastic disorders | |
| IL151890A0 (en) | Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
| IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
| IL150289A0 (en) | Drug combination for the treatment of depression and related disorders comprising mirtazapine | |
| IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
| IL151891A0 (en) | Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
| HUP0102159A3 (en) | Pharmaceutical composition for the treatment of rumen acidosis | |
| IL150290A (en) | Use of mirtazapine for preparation of a medicament for the treatment of sleep disorders | |
| IL155874A0 (en) | Treatment of anxiety disorders | |
| HUP0301553A3 (en) | Pharmaceutical compositions and their use for treating neurological disorders | |
| IL156045A0 (en) | Compositions containing gangliosides for use in the treatment of skin disorders | |
| EE200100527A (et) | Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks | |
| IL158587A0 (en) | Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof | |
| AU2002210763A1 (en) | Use of 1-ebio in the treatment of bipolar disorders | |
| AU4838301A (en) | Treatment of disorders relating to the serotonergic system | |
| IL135993A0 (en) | Pharmaceutical composition for the treatment of fibrosis | |
| HU0003973D0 (en) | Pharmaceutical composition for the treatment of aids | |
| IL153788A0 (en) | Treatment of eating disorders using carboxyalkylethers | |
| GB0021927D0 (en) | Use of pharmaceutical combination | |
| IL152668A0 (en) | Pharmaceutical compositions comprising vip-related peptides for the treatment of sexual disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: N.V. ORGANON, NL Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL |
|
| FD9A | Lapse of provisional protection due to non-payment of fees |